In the BioHarmony Drug Report Database

"Preview" Icon

Varenicline

Chantix, Champix (varenicline) is a small molecule pharmaceutical. Varenicline was first approved as Chantix on 2006-09-25. It has been approved in Europe to treat tobacco use cessation. The pharmaceutical is active against neuronal acetylcholine receptor subunit alpha-4. In addition, it is known to target neuronal acetylcholine receptor subunit alpha-3.

 

Trade Name

 

Champix
 

Common Name

 

varenicline
 

ChEMBL ID

 

CHEMBL1396
 

Indication

 

tobacco use cessation
 

Drug Class

 

Nicotinic acetylcholine receptor partial agonists/agonists

Image (chem structure or protein)

Varenicline structure rendering